[1]
“Meta-analysis on the association between CYP2D6*10 gene polymorphism and disease free survival of breast cancer patients receiving tamoxifen treatment in Asia”, Bangladesh J Pharmacol, vol. 9, no. 4, pp. 652–662, Dec. 2014, doi: 10.3329/bjp.v9i4.20849.